Researchers from Children's Hospital of Philadelphia (CHOP) have found that pediatric-onset rheumatic and inflammatory diseases have distinct genetic architecture compared with those in adults. The ...

In a clinical report issued by the American Academy of Pediatrics and published online June 23 in Pediatrics, guidance is provided for pediatricians regarding the genetic evaluation of developmental ...

For families affected by rare diseases, unexplained developmental delays or medical symptoms often mark the beginning of a “diagnostic odyssey,” a frustrating search for answers and treatment options.

Researchers from Children's Hospital of Philadelphia (CHOP) have found that pediatric-onset rheumatic and inflammatory diseases have distinct genetic architecture compared with adults. The findings, ...

A key lawmaker and Florida State University leaders Wednesday touted a new law that includes offering free genetic screening for newborns and bolstering research on rare pediatric diseases. Gov. Ron ...

Florida State University's Institute for Pediatric Rare Diseases (IPRD) and Sunshine Genetics Pilot Program received $7.5 million in state funding for a newborn genetic screening pilot program. The ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Please provide your email address to receive an email when new articles are posted on . Researchers identified new sites in the placenta where genomic imprinting occurs. This could find previously ...

GeneDx, which specializes in diagnostics for rare and ultra-rare genetic disorders, is helping to get kids the diagnostic attention they need as part of Diagnosis is Power. Currently, one in 10 ...

Host Kathrin Berg leads a conversation with local children pediatric geneticist and counselor. In this episode of the El Paso Physician, our host Kathrin Berg leads a conversation with local children ...

Ocugen (NASDAQ:OCGN) disclosed on Tuesday that its gene therapy candidate, OCU410ST, has been granted rare pediatric disease status by the U.S. FDA. The designation covers the treatment of ...